Antifibrillatory effects of lidoflazine. A clinical study.
D000081:Acetamides / Q000009:adverse effects / Q000627:therapeutic use; D000293:Adolescent; D000328:Adult; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D004562:Electrocardiography; D005260:Female; D006261:Headache / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use; D013575:Syncope / Q000139:chemically induced; D014693:Ventricular Fibrillation / Q000139:chemically induced; D014992:Xylenes / Q000009:adverse effects / Q000627:therapeutic use
D000081:Acetamides; D000889:Anti-Arrhythmia Agents; D010879:Piperazines; D014992:Xylenes